Back

Experimental and natural peripheral HSV-1 infection: Neurotropism and impact on Alzheimer's disease-related molecular markers

Legrand, A.; Boluda, S.; Boukhvalova, M.; Rozenberg, F.; Bottlaender, M.; Lagarde, J.; Sarazin, M.; Helmer, C.; Linard, M.; Delatour, B.

2026-05-12 neuroscience
10.64898/2026.05.07.723559 bioRxiv
Show abstract

Herpes Simplex virus type 1 (HSV-1) is a highly prevalent neurotropic virus from the alphaherpesviruses family. In recent years, a growing body of research has focused on the potential role of HSV-1 infections and recurrent reactivations in the pathophysiology of Alzheimers disease (AD). In particular, it has been hypothesized that HSV-1 could initiate or amplify the formation of neuropathological lesions characteristic of AD. To explore further this hypothesis, we adopted an integrated approach aiming at deciphering the impact of HSV-1 infection on AD molecular markers (A{beta} and Tau pathologies) and combining experimental animal models of in vivo infection, postmortem neuropathological analysis of AD brains, as well as in-vivo clinical analysis in AD patients. In animal models of peripheral (labial) infection with HSV-1 virus, we analyzed viral dissemination from peripheral tissues to the CNS, and the associated neuropathological consequences. Histological and molecular analyses revealed the occurrence of viral material (RNA, proteins) in the brainstem, the primary site of viral neuroinvasion, and in more anterior regions of the brain. Viral signatures were accompanied by early abnormal deposits of A{beta} peptides and accumulation of phosphoTau (pTau) proteins in various brain areas. Neuropathological examination of AD/control participants also underlined the presence of HSV-1 DNA in the human brainstem (pons) that was always associated with local A{beta}/Tau aggregates. Finally, in AD patients, associations were found between HSV-1 seropositivity and neuropathological lesion burden (region-specific Tau and A{beta} deposition detected by neuroimaging). Taken together, these data provide new evidence in favor of the involvement of HSV-1 in the pathophysiology of AD, stressing a possible causal link between HSV-1 infection, neuroinvasion and AD neuropathological hallmarks (A{beta} lesions and tauopathy).

Matching journals

The top 11 journals account for 50% of the predicted probability mass.

1
Neurobiology of Disease
134 papers in training set
Top 0.3%
13.0%
2
International Journal of Molecular Sciences
453 papers in training set
Top 1%
5.0%
3
Neurobiology of Aging
95 papers in training set
Top 0.6%
4.4%
4
Scientific Reports
3102 papers in training set
Top 26%
4.4%
5
Viruses
318 papers in training set
Top 1%
4.3%
6
EMBO Molecular Medicine
85 papers in training set
Top 0.5%
3.7%
7
PLOS ONE
4510 papers in training set
Top 37%
3.7%
8
Journal of Neuroinflammation
50 papers in training set
Top 0.2%
3.1%
9
Alzheimer's Research & Therapy
52 papers in training set
Top 0.8%
3.1%
10
Acta Neuropathologica Communications
81 papers in training set
Top 0.2%
3.1%
11
Acta Neuropathologica
51 papers in training set
Top 0.4%
2.4%
50% of probability mass above
12
Cells
232 papers in training set
Top 1%
2.4%
13
eLife
5422 papers in training set
Top 35%
2.1%
14
ACS Chemical Neuroscience
60 papers in training set
Top 0.8%
2.1%
15
Neuropathology and Applied Neurobiology
14 papers in training set
Top 0.2%
1.8%
16
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
25 papers in training set
Top 0.3%
1.7%
17
Journal of Alzheimer's Disease
43 papers in training set
Top 0.7%
1.7%
18
Biology
43 papers in training set
Top 0.7%
1.7%
19
Frontiers in Neuroscience
223 papers in training set
Top 5%
1.4%
20
European Journal of Neuroscience
168 papers in training set
Top 0.8%
1.3%
21
Alzheimer's & Dementia
143 papers in training set
Top 2%
1.3%
22
Alzheimer's & Dementia: Translational Research & Clinical Interventions
16 papers in training set
Top 0.5%
1.1%
23
Molecular Neurobiology
50 papers in training set
Top 0.6%
1.1%
24
Brain, Behavior, and Immunity
105 papers in training set
Top 2%
1.0%
25
eBioMedicine
130 papers in training set
Top 3%
0.9%
26
Cell Death & Disease
126 papers in training set
Top 2%
0.9%
27
Frontiers in Aging Neuroscience
67 papers in training set
Top 3%
0.8%
28
Journal of Alzheimer’s Disease
39 papers in training set
Top 1%
0.8%
29
Heliyon
146 papers in training set
Top 5%
0.8%
30
Brain
154 papers in training set
Top 4%
0.8%